Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01873300
Collaborator
(none)
5
1
1
30
0.2

Study Details

Study Description

Brief Summary

Endoscopic Esophageal Myotomy (POEM), the research procedure, splits the lower esophageal sphincter muscle fibers from the inside of the esophagus, avoiding several abdominal incisions (belly area cuts), by using an endoscope to create a small cut at the most inner layer of the esophagus to expose the esophageal sphincter muscle fibers from the inside of the esophagus. The investigators are studying whether subjects who undergo Endoscopic Esophageal Myotomy will have similar functional outcome, and at the same time less pain, scar formation and wound infection than with laparoscopic or open surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic Esophageal Myotomy
Phase 1/Phase 2

Detailed Description

The purpose of this research study is to find out more about a less invasive way of doing the surgical procedure (esophageal myotomy) to treat Achalasia.

Achalasia is a disease of the esophagus, where the lower esophageal sphincter fails to relax, causing difficulty in swallowing.

Esophageal myotomy (Heller myotomy) is surgically cutting the muscle fibers of the esophageal sphincter to allow passage of food into the stomach.

Esophageal myotomy is routinely done either by laparoscopic or open surgery. Laparoscopic surgery requires several (about 4 to 5) small incisions in the abdomen to allow the camera and surgical instruments to be introduced into the abdominal cavity to perform the myotomy. In open surgery, a 6- to 8-inch abdominal incision is made to gain access to the abdominal cavity to perform the myotomy.

Endoscopic Esophageal Myotomy (POEM), the research procedure, splits the lower esophageal sphincter muscle fibers from the inside of the esophagus, avoiding several abdominal incisions.

The researchers are investigating how safe Endoscopic Esophageal Myotomy is and how well it works. Additionally, the researchers will assess the level of pain and the amount of scarring subjects has after this surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Endoscopic Esophageal Myotomy for the Treatment of Achalasia
Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Aug 1, 2014
Actual Study Completion Date :
Aug 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: treatment group

Patients undergoing POEM procedure

Procedure: Endoscopic Esophageal Myotomy
Endoscopic mucosotomy, with submucosal tunneling and circular muscular fiber myotomy and mucosa closure.
Other Names:
  • POEM
  • Trans-esophageal endoscopic myotomy
  • Per-oral endoscopic myotomy
  • Endoscopic Heller Myotomy
  • Outcome Measures

    Primary Outcome Measures

    1. Improvement of quality of life and dysphagia symptoms [6 months]

      Patients will be given a quality of life and dysphagia questionare before surgery and at 3 and 6 months after surgery

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of achalasia

    • Age 18-65

    • ASA class 1-2

    Exclusion Criteria:
    • Pregnant women

    • Any prior surgical or endoscopic treatment for achalasia except dilation less than 20 mm

    • Patients who are taking immunosuppressive medications or are immunocompromised Patients on blood thinners or aspirin or with history of bleeding disorders

    • ASA class III patients

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Masschusetts General Hospital Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: David W Rattner, MD, Massachusetts General Hospital
    • Study Director: Ozanan R Meireles, MD, Masschusetts General Hospital / Harvard Medical School

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    David W. Rattner, MD, Professor of Surgery - Harvard Medical School, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT01873300
    Other Study ID Numbers:
    • 2011P001806
    First Posted:
    Jun 10, 2013
    Last Update Posted:
    Apr 9, 2015
    Last Verified:
    Apr 1, 2015
    Keywords provided by David W. Rattner, MD, Professor of Surgery - Harvard Medical School, Massachusetts General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 9, 2015